- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06069167
Bowel Urgency in Inflammatory Bowel Disease (URGENT-1)
Bowel urgency is commonly defined as the sudden need to rush to the bathroom to empty one's bowel. In the field of inflammatory bowel disease (IBD) (including Crohn's disease (CD) and ulcerative colitis (UC)), bowel urgency is part of the top five research priorities for future IBD nursing research, and it is a symptom that patients consider to be most important when prioritizing their disease control. Urgency is a patient-reported outcome associated with compromised quality of life and future risk of hospitalizations, corticosteroids, and colectomy in patients with UC.
A meta-analysis of 321 studies examining bowel urgency revealed that only one-third of these clinical studies clearly defined the concept of bowel urgency. Definition of bowel urgency was heterogeneous as 14 different definitions were identified. In most of these studies, non-validated questionnaires were used. They are based on subjective responses of the patients, and they could determine evaluation bias. These data emphasize the lack of standardization in bowel urgency assessment.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Neuilly-sur-Seine, France, 92200
- Institut des MICI
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female, aged at least 18 years old
- Diagnosis of inflammatory bowel disease according to the European Crohn´s and Colitis Organisation criteria for at least 3 months
- Person who has received full information about the organization of the research and who has not objected to his or her participation and to the use of his or her data
- Person affiliated to or beneficiary of a social security plan
Exclusion Criteria:
- Person unable to comply with study procedures
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of bowel urgency in a cohort of patients with inflammatory bowel disease
Time Frame: Through study completion, an average of 12 months
|
Inability to defer defecation for more than 15 minutes in patients with inflammatory bowel disease
|
Through study completion, an average of 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To identify IBD-related risk factors associated with an increased risk of bowel urgency
Time Frame: Through study completion, an average of 12 months
|
Inability to defer defecation for more than 15 minutes and potentially predictive factors (i.e.
baseline characteristics)
|
Through study completion, an average of 12 months
|
|
Prevalence of bowel urgency in a cohort of Crohn's disease patients
Time Frame: Through study completion, an average of 12 months
|
Inability to defer defecation for more than 15 minutes in patients with Crohn's disease
|
Through study completion, an average of 12 months
|
|
Prevalence of bowel urgency in a cohort of ulcerative colitis patients
Time Frame: Through study completion, an average of 12 months
|
Inability to defer defecation for more than 15 minutes in patients with ulcerative colitis
|
Through study completion, an average of 12 months
|
|
Development of the URGENT index (i.e. inflammatory bowel disease-specific bowel urgency index)
Time Frame: Through study completion, an average of 12 months
|
Components of the index based on variables describing in systematic review Caron B et al.
Clin Gastroenterol Hepatol.
2023 and IBD expert opinion
|
Through study completion, an average of 12 months
|
|
Correlation between the URGENT index and the Urgency Numeric Rating Scale
Time Frame: Through study completion, an average of 12 months
|
Relationships between changes in the URGENT index and changes in the Urgency Numeric Rating Scale
|
Through study completion, an average of 12 months
|
|
Correlation between the URGENT index and a Global Visual Evaluation
Time Frame: Through study completion, an average of 12 months
|
Relationship between changes in the URGENT index and changes in the Global Visual Evaluation on a 10-point visual analog scale ranging from 0 (minimal activity) to 10 (maximal activity)
|
Through study completion, an average of 12 months
|
|
Most appropriate definition of bowel urgency for patients with IBD
Time Frame: Through study completion, an average of 12 months
|
Urgent desire to defecate and/or extreme desire to defecate and/or immediate need to defecate and/or inability to defer defecation for more than 2 minutes and/or inability to defer defecation for more than 5 minutes and/or inability to defer defecation for more than 20 minutes and/or inability to defer defecation for more than 30 minutes and/or having to rush to the toilet and/or not making it to a toilet in time and/or having to stop whatever to have a bowel movement and/or difficult to withstand urge to open bowels and/or running to the bathroom and/or inability to delay bowel movements
|
Through study completion, an average of 12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PIBDC-2023-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Diseases
-
Cook Children's Health Care SystemNot yet recruitingIBD | IBD - Inflammatory Bowel Disease | IBD (Inflammatory Bowel Disease)United States
-
Ningbo Medical Center Lihuili HospitalRecruitingInflammatory Bowel Disease (IBD)China
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingIBD - Inflammatory Bowel DiseaseItaly
-
Chang Kyun LeeChonnam National University Hospital; Kyungpook National University Hospital; Chung-Ang University Hosptial, Chung-Ang University College of Medicine and other collaboratorsRecruitingInflammatory Bowel Disease (IBD)Korea, Republic of
-
Xijing HospitalNot yet recruitingInflammatory Bowel Diseases (IBD)China
-
Assiut UniversityNot yet recruitingInflammatory Bowel Disease (IBD)
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
University of Texas Southwestern Medical CenterEnrolling by invitationInflammatory Bowel Disease | Inflammatory Bowel Disease (IBD)United States
-
University Hospital, GrenobleInstitute for Advanced Biosciences (IAB), GrenobleNot yet recruitingInflammatory Bowel Disease (IBD)France
Clinical Trials on Collection of data related to bowel urgency
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationActive, not recruitingLumbar Spinal StenosisSwitzerland
-
Adhera Health, Inc.Hospital Universitario Virgen MacarenaCompleted
-
University Hospital Inselspital, BerneCompletedCOVID-19Switzerland
-
University Hospital, Basel, SwitzerlandSwiss Personalized Health Network (SPHN); Personalized Health and Related Technologies...TerminatedSepsis | Infection, Bacterial | Severe Community-acquired Pneumonia (sCAP)Switzerland
-
University Hospital, Basel, SwitzerlandSwiss Personalized Health Network (SPHN); Personalized Health and Related Technologies...Recruiting
-
Vilnius UniversityVilnius University Hospital Santaros Klinikos; Institute of Hygiene, Lithuania and other collaboratorsCompletedCardiovascular DiseasesLithuania
-
Methodist Health SystemRecruiting